IP Library Granted Patent US 9,353,178
Granted Patent B2
US 9,353,178 · App. 13/937,852 · Granted May 31, 2016

Stem cell factor inhibitor

Inventors: Nicholas W. Lukacs (Brighton, MI); Vladislav A. Dolgachev (Ann Arbor, MI); Steven L. Kunkel (Ann Arbor, MI); Cory M. Hogaboam (Ann Arbor, MI); Sem H. Phan (Ann Arbor, MI)
Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
C07K16/24C07K16/22A61K2039/505C07K2317/76
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,353,178
App. No.
13/937,852
Granted
May 31, 2016
Kind
B2
Abstract

Provided herein are methods, compositions, and uses relating to inhibitors of stem cell factor. For example, provided herein are antibodies targeting stem cell factor and methods for treating fibrotic and tissue remodeling diseases.

Claims (11)

1. An anti-stem cell factor antibody that specifically binds to stem cell factor isoform b relative to stem cell factor isoform a or an antigen-binding antibody fragment that specifically binds to stem cell factor isoform b relative to stem cell factor isoform a.

2. The anti-stem cell factor antibody or the antigen-binding antibody fragment of claim 1 wherein the antibody or the antigen-binding antibody fragment specifically binds to a protein comprising an amino acid sequence provided by SEQ ID NO: 4 or antibody-binding fragment thereof.

3. The anti-stem cell factor antibody or the antigen-binding antibody fragment of claim 1 wherein the antibody is a monoclonal antibody or the antigen-binding antibody fragment is a fragment of a monoclonal antibody.

4. The anti-stem cell factor antibody or the antigen-binding antibody fragment of claim 1 wherein the antibody is a polyclonal antibody.

5. The anti-stem cell factor antibody or the antigen-binding antibody fragment of claim 1 wherein the antibody is a humanized antibody or the antigen-binding antibody fragment is a fragment of a humanized antibody.

6. The anti-stem cell factor antibody or the antigen-binding antibody fragment of claim 1 wherein the antibody or antigen-binding antibody fragment is a Fab, a Fab′, a F(ab′), a Fv fragment, a scFv fragment, or a linear antibody.

7. A composition comprising the anti-stem cell factor antibody or the antigen-binding antibody fragment of claim 1 .

8. The composition of claim 7 further comprising a stem cell factor isoform b polypeptide.

9. The composition of claim 8 wherein the antibody or antigen-binding antibody fragment is bound to the stem cell factor isoform b polypeptide.

10. The composition of claim 7 comprising a physiologically appropriate solution for administration to a subject.

11. The composition of claim 10 formulated for administration into an airway of a subject.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 14, 2016
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038077/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2013
From: LUKACS, NICHOLAS W.; DOLGACHEV, VLADISLAV A.; KUNKEL, STEVEN L.; HOGABOAM, CORY M.; PHAN, SEM H.
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 031271/0620 →
Continuity (3)
Division 13347459 · Jan 10, 2012
Provisional Application 61431246 · Jan 10, 2011
Related Publication 20140023651A1 · Jan 23, 2014